IKT
IKT
NASDAQ · Biotechnology

Inhibikase Therapeutics Inc

$1.52
-0.01 (-0.65%)
Day Range $1.49 — $1.58
52W Range $1.40 — $2.61
Open$1.56
Previous Close$1.53
Day High$1.58
Day Low$1.49
52W High$2.61
52W Low$1.40
Volume—
Avg Volume557.3K
Market Cap213.21M
P/E Ratio—
EPS$-0.50
SectorBiotechnology

Analyst Ratings

Strong Buy
14 analysts
12 Buy 2 Hold 0 Sell
Price Target +1,742.8% upside
Current
$1.52
Target
$28.01
$19.41 $28.01 avg $39.32

Key Financials

FY 2025 FY 2024 FY 2023
Revenue 78.22M 74.95M 61.90M
Net Income 4.38M 5.16M 3.75M
Profit Margin 5.6% 6.9% 6.1%
EBITDA 7.32M 7.08M 6.90M
Free Cash Flow 4.21M 5.04M 4.89M
Rev Growth +8.7% +15.3% -5.1%
Debt/Equity 0.35 0.45 0.33

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $295.03 +0.20% 50.3 520.47B
AMGN Amgen Inc $469.15 +0.75% 26.9 252.64B
GILD Gilead Sciences Inc $168.08 +0.08% — 208.95B
VRTX Vertex Pharmaceuticals Inc $542.98 +0.81% 33.9 134.82B
REGN Regeneron Pharmaceuticals $959.96 +0.47% 20.4 98.38B
ALNY Alnylam Pharmaceuticals Inc $161.38 -2.22% 7.7 20.98B

IKT News

No news for IKT yet

Quick Stats

Market Cap213.21M
P/E Ratio—
EPS$-0.50
Volume—
SectorBiotechnology